Two-Drug Combo Standard of Care in Advanced Endometrial Cancer Two-Drug Combo Standard of Care in Advanced Endometrial Cancer

Survival outcomes for the combination paclitaxel-carboplatin were similar to those with paclitaxel, doxorubicin, and cisplatin but with lower toxicity.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news